New clinical evidence support potential for glepaglutide as a onceweekly drug for short bowel syndrome SBS

Company announcement No. 52018 New clinical evidence support potential for glepaglutide as a onceweekly drug for short bowel syndrome SBS Zealand has completed a pharmacokinetic PK study with glepaglutide that confirms the potential for onceweekl...